Clinical Trials - Oncology Research

More screened patients participate in clinical trials than the national average.

Clinical trials help determine whether promising treatment approaches should become a new standard of care. The clinical trials may study a new drug, a new approach to surgery, new radiation treatments or combinations of these treatments. The goal is to improve the survival rate for a specific type of cancer.

Areas of clinical trial

The Oncology Research Department in the Methodist Estabrook Cancer Center offers clinical trials to patients at Methodist Estabrook Cancer Center and Methodist Jennie Edmundson Cancer Center. Clinical trials are available in many areas including:

  • Brain
  • Breast
  • Esophageal
  • Gastrointestinal
  • Genitourinary
  • Gynecological
  • Head & Neck
  • Hematological
  • Lung
  • Melanoma
  • Sarcoma

In 2016, an astounding 14% of screened Methodist Estabrook Cancer Center patients were given the opportunity to participate in clinical trials. On average, only 3-5% of cancer patients are accepted into clinical trials nationally.

SOURCE: Patient Data 2016

In addition to closely supervising each study, members of the Oncology Research Department work closely with each patient's physician to determine whether that patient meets the study's criteria for participation.

See a complete listing of available clinical trials.

 

Contact

Methodist Oncology Research
8303 Dodge St.
Omaha, NE 68114

402-354-7939